In Q1 of the fiscal year ending March 2027, revenue fell to 92.2% of the year-earlier level, while operating income turned from a ¥23.6 million profit to a ¥154.1 million loss. With the full-year forecast unchanged, the focus in FY2027-H1 will be whether the company can absorb the impact of license expirations and a shrinking sales network and show signs of earnings recovery.
All recorded disclosures and news since the latest annual or semiannual filing. Switching watchpoints keeps the full history. Select an item to inspect its source.2026-06-26 〜 2026-11-08 · 10 of 10 items
Scroll the timeline →
Whether Q1 revenue recovers to 100% of the year-earlier level (actual: 92.2%)
Whether cumulative H1 operating results return to profitability (Q1 operating loss: ¥154.1 million)
Whether the full-year forecasts of ¥13,118 million in revenue and ¥215 million in operating profit are revised
Whether the impact of license-brand discontinuations, weak mass retailers and a shrinking existing sales network is disclosed by channel
The company's ongoing themes and initiatives this watchpoint touches on.
Revenue in Q1 of the fiscal year ending March 2027 was ¥2,812.1 million, down ¥236.6 million from ¥3,048.8 million in the year-earlier quarter and equivalent to 92.2% of the prior-year level. Operating results turned from a ¥23.6 million profit to a ¥154.1 million loss, ordinary results from a ¥52.0 million profit to a ¥94.9 million loss, and quarterly net income attributable to owners of the parent from a ¥34.0 million profit to an ¥81.3 million loss. The starting point for the next results announcement is that operating, ordinary and net results all deteriorated at the same time, not just revenue.
By segment, revenue in the personal-goods business fell to ¥2,312.5 million, or 89.0% of the year-earlier level, while segment profit contracted from ¥167.2 million to ¥4.4 million. The fragrance business, meanwhile, posted revenue of ¥499.7 million, up 110.8% year on year, but recorded a segment loss of ¥61.98 million. The company cites the expiration of certain license agreements, weakness in the mass-retail market and contraction in some existing sales channels as factors behind the company-wide revenue decline, but has not disclosed a quantitative bridge showing how many millions of yen each factor reduced revenue or profit.
The full-year forecasts are revenue of ¥13,118 million, operating profit of ¥215 million, ordinary profit of ¥350 million and net income attributable to owners of the parent of ¥230 million, unchanged as of Q1. Q1 revenue represented only about 21.4% of the full-year forecast, while operating results started from a ¥154.1 million loss against the full-year forecast. However, the company has not separately disclosed an H1 earnings forecast, so the disclosed figures do not make it possible to determine whether the Q1 loss reflects seasonality or a structural deterioration that undermines the assumptions behind the full-year plan.
In FY2027-H1, the key points will be whether revenue exceeds 100% of the year-earlier level, whether segment profit in the personal-goods business recovers from ¥4.4 million, and whether the fragrance business narrows its loss. It will also be important to see, in millions of yen, how price revisions, raw-material and logistics costs, productivity improvements and higher SG&A each affected profit, and whether the basis for maintaining the ¥215 million full-year operating-profit forecast has been updated.
Revenue (¥ millions)
Select a value or step to inspect its source.
Ordered by date. Disclosures and financial records differ from news and company threads; open each source to inspect it.
2026-11-13 · Awaiting publication
· Awaiting publication
The prior-year comparison for this event
2025-11-13 disclosed · In ¥ millions; each quarter is cumulative from the start of the fiscal year. EPS is in yen.
Latest available: FY2027 Q1
Net salesBusiness scale
6,133JPY m
↗ +9.6% YoYOperating profitCore earnings
70JPY m
YoY unavailableNewest first. The highlighted column is this event’s comparison. YoY uses the same period and accounting basis.
| Metric | FY2027 Q1 | FY2026 full year | FY2026 Q3 | FY2026 Q2Comparison | FY2026 Q1 | FY2025 Q3 | FY2025 Q2 |
|---|---|---|---|---|---|---|---|
| Net sales | 2,812↘ -7.7% YoY | 13,036YoY unavailable | 9,547↗ +3.8% YoY | 6,133↗ +9.6% YoY | 3,048YoY unavailable | 9,201YoY unavailable | 5,594YoY unavailable |
| Operating profit | -154↘ -769.6% YoY | 192YoY unavailable | 135↗ +246.2% YoY | 70YoY unavailable | 23YoY unavailable | 39YoY unavailable | -188YoY unavailable |
| Ordinary profit | -94↘ -280.8% YoY | 321YoY unavailable | 241↗ +84.0% YoY | 127YoY unavailable | 52YoY unavailable | 131YoY unavailable | -132YoY unavailable |
| Net income | -81↘ -338.2% YoY | 186YoY unavailable | 153↘ -27.1% YoY | 78↗ +550.0% YoY | 34YoY unavailable | 210YoY unavailable | 12YoY unavailable |
| Earnings per share | -44.55↘ -333.5% YoY | 102.43YoY unavailable | 83.96↘ -27.1% YoY | 43.15↗ +518.2% YoY | 19.08YoY unavailable | 115.16YoY unavailable | 6.98YoY unavailable |